![(2S,8E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,17,19-tetrahydroxy-8-{[hydroxy(4-methylpiperazin-1-yl)amino]methylidene}-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan](https://static.cymitquimica.com/cas-image/394075-2s-8e-16s-17s-18r-19r-20r-21s-22r-23s-24e-561719-tetrahydroxy-8-hydroxy-4-methylpiperazin-1-yl-amino-methylidene-23-methoxy-241216182022-heptamethyl-1911-trioxo-1289-tetrahydro-27-epoxypentadeca-11113-trienoimino-naphtho-21-b-furan.png)
CAS: 51963-55-4 - (2S,8E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,17,19-tetrahydroxy-8-{[hydroxy(4-methylpiperazin-1-yl)amino]methylidene}-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan
Formule :C43H58N4O13
InChI :InChI=1S/C43H58N4O13/c1-21-12-11-13-22(2)42(55)44-33-28(20-47(56)46-17-15-45(9)16-18-46)37(52)30-31(38(33)53)36(51)26(6)40-32(30)41(54)43(8,60-40)58-19-14-29(57-10)23(3)39(59-27(7)48)25(5)35(50)24(4)34(21)49/h11-14,19-21,23-25,29,34-35,39,49-53H,15-18H2,1-10H3,(H,44,55)/b12-11+,19-14+,22-13-,47-20?/t21-,23+,24+,25+,29-,34-,35+,39+,43-/m0/s1
Code InChI :InChIKey=PADXLTATLMUKBQ-KHLTXFTESA-N
SMILES :O=C(OC1C(C)C(OC)C=COC2(OC3=C(C2=O)C4=C(O)C(C=N(=O)N5CCN(C)CC5)=C(NC(=O)C(=CC=CC(C)C(O)C(C)C(O)C1C)C)C(O)=C4C(O)=C3C)C)C
| Marque | Informations sur le produit | Degré de pureté | Gamme de prix | Livraison estimée |
|---|---|---|---|---|
 | Rifampicin N-oxide REF : 47-400CAS : 51963-55-4 | - - - | 205,00 € | lun 01 Jul 24 |
 | Rifaximin Imine-N-Oxide REF : 4Z-R-359CAS : 51963-55-4 | - - - | À demander | mer 10 Jul 24 |
Ref: 47-400
| 25mg | 205,00 € |
Livraison estimée en/au États-Unis, le lundi 1 juillet 2024
Ref: 4Z-R-359
| 10mg | À demander | ||
| 25mg | À demander | ||
| 50mg | À demander | ||
| 100mg | À demander |
Livraison estimée en/au États-Unis, le mercredi 10 juillet 2024
